RNA-LNP drugs in development

Oligonucleotide therapeutics are the most popular area of RNA-LNP research with 111 trials across 15 indications. Vaccines follow with 95 trials, mostly in infectious diseases and oncology, and gene therapies were a new area of interest with 6 trials.

RNA Lipid Nanoparticle drugs in development by indication:

(Please use a modern browser to see the interactive version of this visualization)